Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug save search
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
Published: 2024-03-20 (Crawled : 13:00) - globenewswire.com
CELU | News F | $3.21 -3.02% -4.42% 42K
|
|
| O: 4.02%
H: 0.74%
C: 0.74%
pda-002 fda drug designation
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
CABA | $13.97 -7.79% -8.52% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.44%
C: 0.67%
caba-201 fda drug granted sclerosis treatment designation
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
iclusig fda drug takeda approval application
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
VTVT | $24.74 2.44% -0.21% 3.4K
|
Health Technology
|
| O: 2.83%
H: 2.85%
C: 1.01%
drug pharmaceuticals glioblastoma
Health Canada Accepts for Review New Drug Submission for Tofersen for Treatment of Rare, Genetic Form of ALS
Published: 2024-03-19 (Crawled : 12:30) - biospace.com/
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -0.33%
H: 1.89%
C: 0.64%
drug health genetic als review treatment canada submission
Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo
Published: 2024-03-19 (Crawled : 04:00) - prnewswire.com
CTSH | $67.13 -0.61% -0.6% 2.4M
|
Technology Services
|
| O: -0.35%
H: 0.72%
C: -0.24%
drug cognizant nvidia
Accelerating the Development of New Molecules - Promethium to Empower ML Models for Drug Discovery Using NVIDIA Quantum Cloud
Published: 2024-03-18 (Crawled : 22:00) - prnewswire.com
PKX | News | $70.1 3.24% 0.0% 110K
|
Non-Energy Minerals
|
| O: -1.31%
H: 0.0%
C: -0.54%
quantum drug cloud nvidia
NVIDIA Healthcare Launches Generative AI Microservices to Advance Drug Discovery, MedTech and Digital Health
Published: 2024-03-18 (Crawled : 21:00) - globenewswire.com
NVDA | News | $846.71 0.76% 0.83% 43M
|
Electronic Technology
|
| O: -1.98%
H: 4.43%
C: 3.11%
drug health nvidia
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published: 2024-03-18 (Crawled : 14:00) - biospace.com/
SCLX | $0.9 -23.08% -30.84% 2.5M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review canada submission
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $0.9 -23.08% -30.84% 2.5M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review treatment canada migraine submission
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K
|
|
| O: 2.94%
H: 14.57%
C: 6.86%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
dfd-29 fda drug corporation treatment medical application
FDA Adcomm Backs Geron’s Anemia Drug for Blood Cancer
Published: 2024-03-15 (Crawled : 12:30) - biospace.com/
GERN | $3.73 1.36% 1.08% 8.4M
|
Health Technology
|
| O: 71.43%
H: 16.33%
C: 12.0%
fda drug anemia cancer blood
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
Published: 2024-03-14 (Crawled : 13:00) - globenewswire.com
BGXX | $0.2226 2.11% 5.18% 390K
|
|
| O: 6.76%
H: 6.47%
C: -10.23%
drug continuation million solar expansion
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
PLUR | $5.05 -2.32% -2.99% 12K
|
Manufacturing
|
| O: 0.55%
H: 0.95%
C: -3.09%
drug cell
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
Published: 2024-03-13 (Crawled : 20:00) - prnewswire.com
PSTX | News | $2.0 -1.96% -1.75% 520K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: -4.14%
fda drug granted treatment designation therapeutics
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
PEPG | $11.845 3.0% 3.36% 47K
|
|
| O: 1.94%
H: 4.94%
C: -2.9%
edo51 fda rare drug disease treatment duchenne
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Global Immune Thrombocytopenia Drug Markets, 2019-2022 and 2023-2029: Advanced Drug Delivery Technologies Transform Management, Second-Generation TPO-RAs Revolutionize Treatment Options
Published: 2024-03-12 (Crawled : 00:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
drug treatment global advanced
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
Published: 2024-03-12 (Crawled : 15:00) - globenewswire.com
BGXX | $0.2226 2.11% 5.18% 390K
|
|
| O: -0.14%
H: 158.62%
C: 45.93%
drug million expansion
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
Published: 2024-03-12 (Crawled : 02:00) - prnewswire.com
CALT | News | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 1.48%
H: 0.44%
C: -2.26%
nefecon fda drug grants therapeutics
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.